Pirfenidone for Idiopathic Pulmonary Fibrosis and Beyond
Pirfenidone (PFD) slows the progression of idiopathic pulmonary fibrosis (IPF) by inhibiting the exaggerated fibrotic response and possibly through additional mechanisms, such as anti-inflammatory effects. PFD has also been evaluated in other fibrosing lung diseases. Myocardial fibrosis is a common...
שמור ב:
| Principais autores: | , , , , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Radcliffe Medical Media
2022-04-01
|
| סדרה: | Cardiac Failure Review |
| גישה מקוונת: | https://www.cfrjournal.com/articleindex/cfr.2021.30 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
